EBioMedicine (Feb 2017)

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection

  • Nao Jounai,
  • Megumi Yoshioka,
  • Miyuki Tozuka,
  • Kazue Inoue,
  • Tatsuya Oka,
  • Kazuki Miyaji,
  • Katsuyasu Ishida,
  • Naoki Kawai,
  • Hideyuki Ikematsu,
  • Chiaki Kawakami,
  • Hiroyuki Shimizu,
  • Masaaki Mori,
  • Ken J. Ishii,
  • Fumihiko Takeshita

DOI
https://doi.org/10.1016/j.ebiom.2017.01.014
Journal volume & issue
Vol. 16, no. C
pp. 124 – 135

Abstract

Read online

Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory tract infections worldwide, especially in infants around 3 to 4 months old. Infants at such a young age have maternally-transferred passive antibodies against RSV but do not have active immune systems efficient enough for the control of RSV infection. In order to elucidate age-specific profiles of immune responses against RSV protection, antibody responses were examined by using blood samples in both acute and convalescent phases obtained from child patients and adult patients. In addition to the serum neutralization activity, antibody responses to the RSV fusion protein (F protein) were dissected by analyzing levels of total IgG, IgG subclasses, the binding stability, and the levels of antibody for the neutralization epitopes. It was suggested that children's antibody responses against RSV are matured over months and years in at least 5 stages based on 1) levels of the neutralization titer and IgG3 for F protein in the convalescent phase, 2) geometric mean ratios of the neutralization titers and levels of IgG1 and IgG2 for F protein in the convalescent phase compared to those levels in the acute phase, 3) the affinity maturation of IgG for F protein and the cross reactivity of IgG for RSV glycoproteins of groups A and B, 4) levels of neutralization epitope-specific IgG, and 5) augmentation of overall antibody responses due to repetitive RSV infection.

Keywords